atezolizumab,oxaliplatin,5-fluorouracil,l-leucovorin,bevacizumab,irinotecan
roche
[' bev ', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'atezo', 'atezotribe']
 atezotribe: os data for folfoxiri + bev vs folfoxiri + atezobev in 1st line #mcrc #asco23 ras mut 71%/74%, braf mut 14%/8, tmbhigh 10%/12%, high is ic 32%/32% mpfs 11.5 vs 13.1 mo mpfs2: 19.9 vs 22.6 mo mos 27.2 vs 33 mo benefit for is ic-high and/or tmb high pmmr 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology